<DOC>
	<DOCNO>NCT01535677</DOCNO>
	<brief_summary>This open-label , randomise study compare similarity combination Dapagliflozin/Metformin tablet two drug administer separately fast feed condition healthy volunteer .</brief_summary>
	<brief_title>To Compare Similarity Combination Dapagliflozin/Metformin Tablet With Two Drugs Administered Separately</brief_title>
	<detailed_description>A Bioequivalence Study Fixed Dose Combination Dapagliflozin/Metformin Tablet ( 5.0 mg/850 mg ) Relative 5.0 mg Dapagliflozin Tablet 850 mg Metformin ( Glucophage® Marketed Canada Sanofi-Aventis ) Tablet Co-Administered Healthy Subjects Fasted Fed States</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy volunteer age 18 55 year inclusive suitable vein cannulation repeat vein puncture Male subject willing use barrier contraception ie , condom spermicide , day dose least 3 month dose investigational product Nonpregnant , nonlactating female subject premenopausal use adequate birth control eg , oral , injectable , transdermal implant hormonal contraceptive , vaginal contraceptive ring , intrauterine device ( IUD ) /intrauterine system Have body mass index ( BMI ) 18.5 30.0 kg/m2 inclusive ( ie , within 15 % normal range ) weigh least 50 kg 100 kg . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically important abnormality rhythm , conduction morphology rest ECG may interfere individual safety evaluation Current smoker smoke 5 cigarette per day ( equivalent use tobacco product ) give smoke study Excessive intake caffeine contain drink eg , coffee , tea , caffeine contain energy drink cola ( 5 cup coffee equivalent per day ) Plasma donation within one month screen blood donation/blood loss &gt; 500 mL 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>cross-over study</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Cmax</keyword>
	<keyword>tmax</keyword>
	<keyword>AUC</keyword>
	<keyword>AUC ( 0-t )</keyword>
	<keyword>λz</keyword>
	<keyword>tlast</keyword>
</DOC>